Insulin glulisine is a rapidly acting analogue with a pharmacokinetic profile that is similar to those of insulin lispro and insulin aspart. [48] It is created by substituting lysine for ...

However, the reluctance in adoption of rapid acting insulin due to the side effect, such as hypoglycemia, may hinder the growth of the industry. Conversely, untapped market and undiagnosed population ...